[Federal Register Volume 71, Number 36 (Thursday, February 23, 2006)]
[Notices]
[Pages 9333-9336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-2576]
[[Page 9333]]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[FRL-8036-1; Docket No. ORD 2003-0016]
Integrated Risk Information System (IRIS); Announcement of 2006
Program
AGENCY: Environmental Protection Agency.
ACTION: Notice; announcement of IRIS 2006 program agenda.
-----------------------------------------------------------------------
SUMMARY: The U.S. Environmental Protection Agency (EPA) is announcing
the IRIS 2006 agenda.
The Integrated Risk Information System (IRIS) is an EPA database
that contains the Agency's scientific positions on human health effects
that may result from exposure to chemical substances in the
environment. On March 4, 2005, EPA announced the 2005 IRIS agenda
(42FR10616), with solicitation of scientific information from the
public for consideration in assessing health effects from specific
chemical substances. All assessments currently in progress are listed
in this notice. EPA is not initiating new assessments in 2006 in order
to focus on completion of existing assessments. This notice also
provides an update on EPA's efforts to improve the IRIS health
assessment development and review processes.
DATES: While EPA is not expressly soliciting comments on this notice,
the Agency will accept information related to the substances included
herein. Please submit any information in accordance with the
instructions provided at the end of this notice.
ADDRESSES: Please submit relevant scientific information identified by
docket ID number EPA-HQ-ORD-2003-0016, online at http://www.regulations.gov (EPA's preferred method); by e-mail to
[email protected]; mailed to EPA Docket Center, Environmental
Protection Agency, Mail Code: 2822T, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001; or by hand delivery or courier to EPA Docket
Center, EPA West, Room B102, 1301 Constitution Ave., NW., Washington,
DC, between 8:30 a.m. and 4:30 p.m. Monday through Friday, excluding
legal holidays. Comments on a disk or CD-ROM should be formatted in
Word or as an ASCII file, avoiding the use of special characters and
any form of encryption, and may be mailed to the mailing address above.
FOR FURTHER INFORMATION CONTACT: For information on the IRIS program,
contact Amy Mills, IRIS Program Director, National Center for
Environmental Assessment, (mail code: 8601D), Office of Research and
Development, U.S. Environmental Protection Agency, Washington, DC.
20460; telephone: (202) 564-3204, facsimile: (202) 565-0075; or e-mail:
[email protected].
For general questions about access to IRIS, or the content of IRIS,
please call the IRIS Hotline at (202) 566-1676 or send electronic mail
inquiries to [email protected].
SUPPLEMENTARY INFORMATION:
Background
IRIS is an EPA database containing Agency scientific positions on
potential adverse human health effects that may result from exposure to
chemical substances found in the environment. (EPA notes that
information in the IRIS database has no preclusive effect and does not
predetermine the outcome of any rulemaking. When EPA uses such
information to support a rulemaking, the scientific basis for, and the
application of, that information are subject to comment.) IRIS
currently provides information on health effects associated with more
than 500 chemical substances.
The database includes chemical-specific summaries of qualitative
and quantitative health information in support of the first two steps
of the risk assessment process, i.e., hazard identification and dose-
response evaluation. Combined with specific situational exposure
assessment information, the information in IRIS is an important source
in evaluating potential public health risks from environmental
contaminants.
EPA's overall process for developing IRIS assessments consists of:
(1) An annual Federal Register announcement of EPA's IRIS agenda and
call for scientific information from the public on selected chemical
substances; (2) a search of the scientific literature; (3) development
of IRIS Summaries and support documents; (4) EPA-wide review; (5)
external peer review; (6) management review and approval; and (7) entry
of IRIS Summaries and support documents into the IRIS database (http://www.epa.gov/iris).
The IRIS Annual Agenda
Each year, EPA develops an annual agenda for the IRIS program and
announces new assessments under review. A focus of the IRIS Program for
2006 is to move forward the 76 assessments already in progress. In
light of this focus, EPA will not initiate any new assessments in 2006.
This notice provides: (1) A list of IRIS assessments in progress; (2)
an update on improvements made to the IRIS program and preliminary
notice of further improvements under consideration.
Assessments in Progress
The following assessments are underway. Each was listed in the 2005
IRIS agenda. The status and planned milestone dates for each assessment
can be found on the IRIS Track system, accessible from the IRIS
database. All health endpoints due to chronic exposure, cancer and
noncancer, are being assessed unless otherwise noted. For all endpoints
assessed, both qualitative and quantitative assessments are being
developed where information is available. Those substances denoted with
an asterisk (*) may require additional time for analysis or peer review
due to their large databases or complex assessment issues. Substances
denoted with a double asterisk (**) are being evaluated for effects
from acute and/or other less-than-lifetime exposure durations. These
substances are part of a pilot test to evaluate the application of
methods, procedures, and resource needs for adding health effects
information for less-than-lifetime exposure durations to IRIS.
Additional less-than-lifetime durations may be added to ongoing chronic
assessments as needs arise and resources permit.
[[Page 9334]]
------------------------------------------------------------------------
Substance name CAS No.
------------------------------------------------------------------------
acetaldehyde...................................... 75-07-0
acrolein**........................................ 107-02-8
acrylamide........................................ 79-06-1
acrylonitrile..................................... 107-13-1
aldicarb/aldicarb sulfoxide....................... 116-06-3/1646-87-3
aldicarb sulfone.................................. 1646-88-4
arsenic........................................... 7440-38-2
asbestos*......................................... 1332-21-4
benzene**......................................... 71-43-2
benzo(a)pyrene.................................... 50-32-8
beryllium (cancer effects)........................ 7440-41-7
bromobenzene...................................... 108-86-1
bromodichloro methane............................. 75-27-4
bromoform......................................... 75-25-2
butyl benzyl phthalate............................ 85-68-7
cadmium........................................... 7440-43-9
carbon tetrachloride.............................. 56-23-5
cerium............................................ 1306-38-3
chloroethane...................................... 75-00-3
chloroform (inhalation route)..................... 67-66-3
chloroprene....................................... 126-99-8
cobalt............................................ 7440-48-4
copper............................................ 7440-50-8
Cryptosporidium................................... (\2\)
dibromochloro methane............................. 124-48-1
dibutyl phthalate (chronic; less-than-lifetime** 84-74-2
exposures).......................................
1,2-dichlorobenzene............................... 95-50-1
1,3-dichlorobenzene............................... 541-73-1
1,4-dichlorobenzene............................... 106-46-7
1,2-dichloroethylene.............................. 540-59-0
di(2-ethylhexyl)adipate (DEHA).................... 103-23-1
di(2-ethylhexyl) phthalate........................ 117-81-7
1,4-dioxane....................................... 123-91-1
ethanol........................................... 64-17-5
ethyl tertiary butyl ether........................ 637-92-3
ethylbenzene...................................... 100-41-4
ethylene dichloride............................... 107-06-2
ethylene glycol monobutyl ether (cancer effects).. 111-76-2
ethylene oxide (cancer effects; noncancer acute** 75-21-8
exp.)............................................
formaldehyde*..................................... 50-00-0
hexachlorobutadiene............................... 87-68-3
hexachloroethane.................................. 67-72-1
hexachlorocyclo pentadiene**...................... 77-47-4
hexahydro-1,3,5-trinitro-triazine (RDX)........... 121-82-4
2-hexanone........................................ 591-78-6
hydrogen cyanide.................................. 74-90-8
hydrogen sulfide**................................ 7783-06-4
isopropanol....................................... 67-63-0
kepone............................................ 43-50-0
methanol.......................................... 67-56-1
methyl tert-butyl ether (MTBE).................... 1634-04-4
methylene chloride (dichloromethane).............. 75-09-2
mirex............................................. 2385-85-5
naphthalene (inhalation route)*................... 91-20-3
nickel (soluble salts)............................ (\2\)
nitrobenzene...................................... 98-95-3
PAH mixtures*..................................... (\2\)
pentachlorophenol................................. 87-86-5
perfluorooctanoic acid-ammonium salt (PFOA)....... 3825-26-1
perfluorooctane sulfonate-potassium salt (PFOS)... 2795-39-3
phosgene (acute** exposure)....................... 75-44-5
platinum.......................................... 7440-06-4
polybrominated diphenyl ethers (tetra, penta, (\2\)
hexa, deca-BDEs).................................
polychlorinated biphenyls (PCBs) (noncancer 1336-36-3
endpoints).......................................
propionaldehyde................................... 123-38-6
refractory ceramic fibers......................... (\1\)
styrene........................................... 100-42-5
2,3,7,8-TCDD (dioxin)*............................ 1746-01-6
1,1,2,2-tetrachloroethane (chronic; less-than- 79-34-5
lifetime** exp.).................................
tetrachloroethylene (perchloroethylene)........... 127-18-4
tetrahydrofuran................................... 109-99-9
thallium.......................................... 7440-28-0
trichloroacetic acid.............................. 76-03-9
1,1,1-trichloroethane (chronic; less-than- 71-55-6
lifetime** exp.).................................
[[Page 9335]]
trichloroethylene*................................ 79-01-6
1,2,3-trichloropropane............................ 96-18-4
2,2,4-trimethylpentane............................ 540-84-1
uranium compounds................................. (\2\)
vinyl acetate..................................... 108-05-4
------------------------------------------------------------------------
\1\ Not applicable.
\2\ Not applicable--various.
Note that the asbestos noncancer assessment has been expanded to
include cancer effects. This is the only substantive change to the 2005
IRIS agenda.
IRIS Summaries and support documents for all substances listed as
on-going assessments in 2006 will be provided on the IRIS Web site at
http://www.epa.gov/iris as they are completed. This publicly available
Web site is EPA's primary location for IRIS documents. In addition,
external peer review drafts of IRIS assessments are posted for public
information and comment. These drafts will continue to be accessible
via the IRIS and NCEA Web sites. Note that these drafts are intended
for public information only, and do not represent the Agency's final
position.
Other Improvements to the IRIS Program--Update
As discussed in the Federal Register notice announcing the 2005
agenda, EPA is improving the IRIS program and its products through a
series of program reforms. EPA has expanded its central IRIS Staff to
better manage the program and promote scientific quality and
consistency. In addition, external scientific peer reviews are being
conducted routinely by panel meetings rather than by mail reviews. This
step is being taken to provide the best possible scientific evaluation
of each assessment. Further, EPA now conducts each external peer review
at the end of each IRIS assessment review process, strengthening the
role of peer review in informing the outcome of the process. A public
comment period prior to panel peer review meetings is now standard
practice, and the meetings are open to the public for observation.
These program reforms facilitate scientific input from the public and
make the peer review process more transparent.
Further enhancements to the IRIS assessment development and review
process are currently under consideration. A follow-up notice will be
published in the Federal Register to announce a public workshop on
proposed additions to the IRIS process in 2006.
General Information
As of Monday, November 28, 2005, EPA's EDOCKET was replaced by the
Federal Docket Management System (FDMS), the new federal government-
wide system. FDMS was created to provide a single point of access to
all federal rulemaking activities. All materials previously found in
EDOCKET are now available on the Internet at http://www.regulations.gov.
A. How Can I Get Copies of Related Information?
EPA has established an official public docket for this action under
Docket ID No. ORD 2003-0016. The official public docket is the
collection of materials that is available for public viewing at the
Office of Environmental Information (OEI) Docket in the EPA Docket
Center, EPA West, Room B102, 1301 Constitution Ave., NW., Washington,
DC. The EPA Docket Center Public Reading Room is open from 8:30 a.m. to
4:30 p.m., Monday through Friday, excluding legal holidays. The
telephone number for the Public Reading Room is (202) 566-1744, and the
telephone number for the OEI Docket is (202) 566-1752.
An electronic version of the public docket is available through
EPA's electronic public docket and comment system. EPA Dockets at
http://www.regulations.gov may be used to submit or view public
submissions, access the index listing of the contents of the official
public docket, and to access those documents in the public docket that
are available electronically. Once in the system, select ``search,''
then key in the appropriate docket identification number.
It is important to note that EPA's policy is that public
submissions, whether submitted electronically or in paper, will be made
available for public viewing in EPA's electronic public docket as EPA
receives them and without change, unless the submission contains
copyrighted material, CBI, or other information whose disclosure is
restricted by statute. Information claimed as CBI and other information
whose disclosure is restricted by statute is not included in the
official public docket or in EPA's electronic public docket. EPA's
policy is that copyrighted material, including copyrighted material
contained in a public comment, will not be placed in EPA's electronic
public docket but will be available only in printed, paper form in the
official public docket. Although not all docket materials may be
available electronically, you may still access any of the publicly
available docket materials through the EPA Docket Center.
B. How and To Whom Do I Submit Information?
Information on chemical substances listed in this notice may be
submitted as provided in the ADDRESSES section. If you submit
electronic information, EPA recommends that you include your name,
mailing address, and an e-mail address or other contact information in
the body of your submission and with any disk or CD-ROM you submit.
This ensures that you can be identified as the submitter of the
information and allows EPA to contact you in case EPA cannot read your
information due to technical difficulties or needs further information
on the substance of your submission. Any identifying or contact
information provided in the body of submitted information will be
included as part of the submission information that is placed in the
official public docket, and made available in EPA's electronic public
docket. If EPA cannot read your information due to technical
difficulties and cannot contact you for clarification, EPA may not be
able to consider your information.
Your use of EPA's electronic public docket to submit information to
EPA electronically is EPA's preferred method for receiving submissions.
The electronic public docket system is an ``anonymous access'' system,
which means EPA will not know your identity, e-mail address, or other
contact information unless you provide it in the body of your
submission. In contrast to EPA's electronic public docket, EPA's
electronic mail (e-mail) system is not an ``anonymous access'' system.
If you send e-mail directly to the Docket without going through EPA's
electronic public docket, your e-mail address is automatically captured
and included as
[[Page 9336]]
part of the submission that is placed in the official public docket,
and made available in EPA's electronic public docket.
Dated: February 15, 2006.
Peter Preuss,
Director, National Center for Environmental Assessment.
[FR Doc. E6-2576 Filed 2-22-06; 8:45 am]
BILLING CODE 6560-50-P